Institutional investors purchased a net $17.0 million shares of IMMU during the quarter ended June 2017, and now own 78.42% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIDELITY MANAGEMENT & RESEARCH C... Bought 4.0 Million shares of Immunomedics Inc
ORBIMED ADVISORS LLC Bought 3.7 Million shares of Immunomedics Inc
PALO ALTO INVESTORS LLC Bought 3.0 Million shares of Immunomedics Inc